Mariagrazia Felisi

Drug use in children: cohort study in three European countries

Miriam Sturkenboom, Katia Verhamme, A. Nicolosi et al. · BMJ · 2008 · 242 citations · Full text

Medicine, Pediatrics, Pharmacology +11

The safety and effectiveness of deferiprone in a large‐scale, 3‐year study in Italian patients

Adriana Ceci, Paola Baiardi, Mariagrazia Felisi et al. · British Journal of Haematology · 2002 · 216 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Defining off-label and unlicensed use of medicines for children: Results of a Delphi survey

Antje Neubert, Ian Chi Kei Wong, A. Bonifazi et al. · Pharmacological Research · 2008 · 114 citations

Pharmacy, Child Health, Pediatrics +14

Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years

Adriana Ceci, Mariagrazia Felisi, Paola Baiardi et al. · European Journal of Clinical Pharmacology · 2006 · 75 citations

Pharmacy, Pediatric Pharmacy, Pediatrics +9

Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial

Aurelio Maggio, Antonis Kattamis, Mariagrazia Felisi et al. · The Lancet Haematology · 2020 · 72 citations

Medicine, Pediatrics, Pharmacology +11